R. Officinalis as Pulpotomy Agent in Permanent Teeth With Irreversible Pulpitis

Starting soon · Not applicable

Conditions studied: Irreversible Pulpitis, Pulpotomy, MTA Vital Tooth Pulpotomy

In brief

This study evaluates and compares the clinical and radiographic outcomes of Rosmarinus officinalis and Mineral Trioxide Aggregate (MTA) when used as pulpotomy medicaments in vital mature permanent teeth with irreversible pulpitis. The aim is to determine the effectiveness of both materials in terms of pain reduction and periapical healing. While MTA is considered a gold standard, it has limitations such as high cost, long setting time, and potential discoloration. Therefore, this study investigates Rosmarinus officinalis as a natural, cost-effective alternative with comparable therapeutic potential. This study also provide an alternative to RCT in teeth with irreversible pulpitis

Key facts

Study ID
NCT07610057
Run by
University of Health Sciences Lahore
People needed
100
Starts
2026-06-01
Expected to finish
2026-12-31
Last updated by the study team
2026-05-27

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.